Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.
Related coverage: 'Surviving cancer isn't the end of the story' BBC
This story was aggregated from BBC. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.
Read the full story →Related coverage: mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice UMass Chan Medical School
UMass Chan Medical School · 5 hours ago
Related coverage: Seattle Children’s gets $700k in grants for pediatric cancer research kiro7.com
kiro7.com · 8 hours ago
Related coverage: New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says ksl.com Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer Nature Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib Medscape Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ Chicago Tribune Stanford expands access to revolutionary pancreatic cancer drug Stanford Medicine
ksl.com · 8 hours ago
Related coverage: MU School of Medicine receives $1 million cancer research grant Columbia Missourian
Columbia Missourian · 10 hours ago